510(k) Report

510(k) · Cleared

Cleared

Exactech® Vantage® Total Ankle System

K230717510(k) TraditionalCleared Oct 12, 2023211-day reviewClass II21 CFR 888.3110

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Exactech, Inc. · HSN Prosthesis, Ankle, Semi-Constrained, Cemented, Metal/Polymer

Cleared on Oct 12, 2023 as substantially equivalent to K152217 (Exactech, Inc., 2016) after a 211-day review. Its family tree reaches back 7 generations to 1992.

Decided
Oct 12, 2023
Review
211 days
Class
Class II
Product code
HSN
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K920802 (1992). 11 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 7 generations backK920802 Alvine Total AnkleDepuy, Inc. · 1992
  2. 6 generations backK020541 Agility Ankle Revision ProsthesisDepuy, Inc. · 2002
  3. 5 generations backK051023 Topez Total Ankle ReplacementTopez Orthopedics, Inc. · 2005 · Recalled
  4. 4 generations backK100886 Inbone II Total Ankle ReplacementWrightmedicaltechnologyinc · 2010 · Recalled
  5. 3 generations backK123954 Infinity Total Ankle SystemWrightmedicaltechnologyinc · 2013 · Recalled
  6. 2 generations backK140749 Infinity Total Ankle SystemWrightmedicaltechnologyinc · 2014 · Recalled
  7. 1 generation backK152217 Exactech Vantage Total Ankle SystemExactech, Inc. · 2016 · Recalled
  8. This deviceK230717 Exactech® Vantage® Total Ankle SystemExactech, Inc. · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K920802Alvine Total AnkleDepuy, Inc.1992—
−6K020541Agility Ankle Revision ProsthesisDepuy, Inc.2002—
−5K051023Topez Total Ankle ReplacementTopez Orthopedics, Inc.20054
−4K100886Inbone II Total Ankle ReplacementWrightmedicaltechnologyinc20102
−3K123954Infinity Total Ankle SystemWrightmedicaltechnologyinc20132
−2K140749Infinity Total Ankle SystemWrightmedicaltechnologyinc20141
−1K152217Exactech Vantage Total Ankle SystemExactech, Inc.20166
0 (this device)K230717Exactech® Vantage® Total Ankle SystemExactech, Inc.2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200620
200910
201010
FIG. 1 — Lineage of K230717, 1992–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HSN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HSN device

  1. #1 K192994 Paragon 28 APEX 3D Total Ankle Replacement…score 16.7 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K152217Exactech Vantage Total Ankle System
Summary page 4
…l Plates • 3D/3D+ Locking Clips The proposed devices have the same indications for use and similar design characteristics as their predicate devices (cleared under K152217). The proposed tibial plates differ from the predicate in that they are additively manufactured, have minor geometrical modificat…
Exactech, Inc.20166
†K192097Exactech® Equinoxe® Stemless Humeral ComponentsExactech, Inc.2020—

Also cleared against K152217: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 31 years and passes through 4 companies; a new generation was cleared every 3.5 years on median.
  • 7 of the 11 ancestors have a recall of any class.
  • 4 other devices also cite its predicate K152217.

How does its category compare?

All HSN devices

HSN Prosthesis, Ankle, Semi-Constrained, Cemented, Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · HSN

3in 2025

2009: 12010: 22011: 12012: 22013: 42014: 22015: 32016: 32017: 42018: 42019: 22020: 62021: 42022: 12023: 62024: 72025: 32026 (partial year): 2
2007high 7 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HSN

58in 2025

2013: 89 days median2015: 233 days median2016: 216 days median2017: 148 days median2018: 89 days median2020: 234 days median2021: 109 days median2023: 112 days median2024: 115 days median2025: 58 days median
2007high 234 (2020) · low 58 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HSN

1in 2023

2013: 32016: 12017: 22019: 12021: 32022: 22023: 1
2007high 3 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HSN

1,645in 2025

2007: 502008: 662009: 662010: 1202011: 1392012: 1002013: 1062014: 652015: 732016: 1112017: 962018: 1872019: 2772020: 2812021: 2372022: 4532023: 7962024: 1,0952025: 1,645
2007high 1,645 (2025) · low 50 (2007)2025

MAUDE reports naming product code HSN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—050
20080—066
20091—066
20102—0120
20111—0139
20122—0100
20134893106
20142—065
20153233073
201632161111
20174148296
20184890187
20192—1277
202062340281
202141093237
20221—2453
202361121796
2024711501,095
202535801,645
20262—0—

What is it indicated for?

The Vantage® Total Ankle System is indicated for patients with ankle joints damaged by severe rheumatoid, post-traumatic, or degenerative arthritis. It is also indicated for revision of failed previous reconstructions where sufficient bone stock and soft tissue integrity are present.

The Vantage® Total Ankle System is indicated for cemented use only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K230717: Exactech® Vantage® Total Ankle System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K230717

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026